|
WO2015057724A1
|
|
Use of g-csf for treating or preventing villitis of unknown etiology in a human female
|
|
WO2010126553A1
|
|
Compositions and methods for reducing the likelihood of implantation failure or spontaneous abortion in recipients of assisted reproduction
|
|
US2009226397A1
|
|
Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
|
|
WO2010126528A1
|
|
Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
|
|
US2011171168A1
|
|
Human g-csf analogs and methods of making and using thereof
|
|
EP2274325A1
|
|
Human g-csf analogs and methods of making and using thereof
|
|
EP1682074A2
|
|
Compositions and methods for healthy pregnancy
|
